Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves
- 1 July 2007
- journal article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 68 (7), 788-796
- https://doi.org/10.2460/ajvr.68.7.788
Abstract
Objective—To evaluate protection resulting from use of a modified-live noncytopathic bovine viral diarrhea virus (BVDV) type 1 vaccine against systemic infection and clinical disease in calves challenged with type 2 BVDV. Animals—10 calves, 5 to 7 months of age. Procedures—Calves were allocated (n = 5/group) to be nonvaccinated or vaccinated SC on day 0 with BVDV 1 (WRL strain). Calves in both groups were challenged intranasally with BVDV type 2 isolate 890 on day 21. Rectal temperatures and clinical signs of disease were recorded daily, and total and differential WBC and platelet counts were performed. Histologic examinations and immunohistochemical analyses to detect lesions and distribution of viral antigens, respectively, were performed. Results—After challenge exposure to BVDV type 2, nonvaccinated calves developed high rectal temperatures, increased respiratory rates, viremia, leukopenia, lymphopenia, and infection of the thymus. Vaccinated calves did not develop high rectal temperatures or clinical signs of respiratory tract disease. Vaccinated calves appeared to be protected against systemic replication of virus in that they did not develop leukopenia, lymphopenia, viremia, or infection of target organs, and infectious virus was not detected in peripheral blood mononuclear cells or the thymus. Conclusions and Clinical Relevance—The modified-live BVDV type 1 vaccine protected against systemic infection and disease after experimental challenge exposure with BVDV type 2. The vaccine protected calves against infection and viremia and prevented infection of target lymphoid cells.Keywords
This publication has 16 references indexed in Scilit:
- Characterization of protection from systemic infection and disease by use of a modified-live noncytopathic bovine viral diarrhea virus type 1 vaccine in experimentally infected calvesAmerican Journal of Veterinary Research, 2005
- Origination and consequences of bovine viral diarrhea virus diversityVeterinary Clinics of North America: Food Animal Practice, 2004
- The immune response to bovine viral diarrhea virus: a constantlychanging pictureVeterinary Clinics of North America: Food Animal Practice, 2004
- Comparative virulence of isolates of bovine viral diarrhea virus type II in experimentally inoculated six- to nine-month-old calvesAmerican Journal of Veterinary Research, 2002
- Monoclonal antibodies to the E2 protein of a new genotype (type 2) of bovine viral diarrhea virus define three antigenic domains involved in neutralizationVirus Research, 1998
- Differentiation of types 1a, 1b and 2 bovine viral diarrhoea virus (BVDV) by PCRMolecular and Cellular Probes, 1998
- Molecular Biology of Bovine Viral Diarrhea Virus and its Interactions with the HostVeterinary Clinics of North America: Food Animal Practice, 1995
- Segregation of Bovine Viral Diarrhea Virus into GenotypesVirology, 1994
- Bovine viral diarrhea virus proteins and their antigenic analysesPublished by Springer Science and Business Media LLC ,1991
- Comparisons of the Pestivirus Bovine Viral Diarrhoea Virus with Members of the FlaviviridaeJournal of General Virology, 1988